Literature DB >> 3923382

Polyamine reutilization and turnover in brain.

N Seiler, F N Bolkenius.   

Abstract

N1,N2-bis-(2,3-butadienyl)-1,4-butanediamine (MDL 72527) is an irreversible, specific inhibitor of polyamine oxidase, which allows one to completely inactivate this enzyme in all organs of an experimental animal. As a result one observes a linear increase of N1-acetylspermidine and N1-acetylspermine concentrations in brain. The rate of accumulation seems directly proportional to the rate of spermidine, and spermine degradation respectively, and since no compensatory changes of the polyamine synthetic enzymes were induced by inhibition of polyamine oxidase, the rate of acetyl-polyamine accumulation is assumed to be a measure for polyamine turnover. The decrease of brain putrescine levels by 70 percent in the brains of MDL 72527-treated animals suggests the quantitative significance of putrescine reutilisation. Pretreatment of the animals with D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase reduced both, polyamine turnover rate and the extent of putrescine reutilization. Inhibition of GABA-T produced a significant increase of polyamine turnover in brain, in agreement with the known induction of ornithine decarboxylase activity after treatment with inhibitors of GABA-T.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923382     DOI: 10.1007/bf00964656

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  IDENTIFICATION OF THE AMINOALDEHYDES PRODUCED BY THE OXIDATION OF SPERMINE AND SPERMIDINE WITH PURIFIED PLASMA AMINE OXIDASE.

Authors:  C W TABOR; H TABOR; U BACHRACH
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.

Authors:  M J Jung; B Lippert; B W Metcalf; P J Schechter; P Böhlen; A Sjoerdsma
Journal:  J Neurochem       Date:  1977-04       Impact factor: 5.372

3.  The effect of DL-allylglycine on polyamine and GABA metabolism in mouse brain.

Authors:  A E Pajunen; O A Hietala; E L Baruch-Virransalo; R S Piha
Journal:  J Neurochem       Date:  1979-05       Impact factor: 5.372

4.  Distribution of putreanine in organs of rats and rabbits.

Authors:  T Nakajima; Y Matsuoka
Journal:  J Neurochem       Date:  1971-12       Impact factor: 5.372

5.  Acetylderivatives as intermediates in polyamine catabolism.

Authors:  F N Bolkenius; N Seiler
Journal:  Int J Biochem       Date:  1981

6.  Decreased protein-synthetic activity is an early consequence of spermidine depletion in rat hepatoma tissue-culture cells.

Authors:  B B Rudkin; P S Mamont; N Seiler
Journal:  Biochem J       Date:  1984-02-01       Impact factor: 3.857

7.  Regulatory interrelations between GABA and polyamines. I. Brain GABA levels and polyamine metabolism.

Authors:  N Seiler; G Bink; J Grove
Journal:  Neurochem Res       Date:  1979-08       Impact factor: 3.996

8.  gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice.

Authors:  M J Jung; B Lippert; B W Metcalf; P Böhlen; P J Schechter
Journal:  J Neurochem       Date:  1977-11       Impact factor: 5.372

9.  On the turnover of polyamines spermidine and spermine in mouse brain and other organs.

Authors:  H Antrup; N Seiler
Journal:  Neurochem Res       Date:  1980-02       Impact factor: 3.996

10.  Polyamine biosynthesis and interconversion in rodent tissues.

Authors:  A E Pegg; J E Seely; H Pösö; F della Ragione; I A Zagon
Journal:  Fed Proc       Date:  1982-12
View more
  10 in total

Review 1.  Oxidation of polyamines and brain injury.

Authors:  N Seiler
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 2.  Recent advances in the biochemistry of polyamines in eukaryotes.

Authors:  A E Pegg
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

3.  Purification and characterization of polyamine oxidase from Ascaris suum.

Authors:  S Müller; R D Walter
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

4.  Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal.

Authors:  Svetlana Ivanova; Franak Batliwalla; J Mocco; Szilard Kiss; Judy Huang; William Mack; Alexander Coon; John W Eaton; Yousef Al-Abed; Peter K Gregersen; Esther Shohami; E Sander Connolly; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

Review 5.  Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival.

Authors:  Gad M Gilad; Varda H Gilad
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

6.  Polyamine catabolism is enhanced after traumatic brain injury.

Authors:  Kamyar Zahedi; Francis Huttinger; Ryan Morrison; Tracy Murray-Stewart; Robert A Casero; Kenneth I Strauss
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

7.  3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin.

Authors:  Wei Li; Xi-Ming Yuan; Svetlana Ivanova; Kevin J Tracey; John W Eaton; Ulf T Brunk
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

8.  Spermine interacts with cocaine binding sites on dopamine transporters.

Authors:  M C Ritz; C R Mantione; E D London
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

9.  Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain.

Authors:  G Daune; N Seiler
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

10.  Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death.

Authors:  S Ivanova; G I Botchkina; Y Al-Abed; M Meistrell; F Batliwalla; J M Dubinsky; C Iadecola; H Wang; P K Gregersen; J W Eaton; K J Tracey
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.